Role of Platelet-rich Plasma injection in ear in sensorineural hearing loss

Role of intratympanic injection of Platelet-rich Plasma in sensorineural hearing loss - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/105789

Enrollment

196

Registered

2026-03-10

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H838- Other specified diseases of innerear

Interventions

Intervention1: Platelet rich plasma: Injecting 0.5ml PRP intratympanically in SNHL patients

Eligibility

Inclusion criteria

Inclusion criteria: Patients with snhl with duration of symptoms less than 6months Intact tympanic membrane

Exclusion criteria

Exclusion criteria: Cases with chl and mixed hearing loss Perforated tympanic membrane Presbycusis Retrocochlear pathology Post ct rt M ni re s disease Recent use of ototoxic drugs

Design outcomes

Primary

Measure	Time frame
Effect in hearing in snhlTimepoint: 3 months	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactJaseetha S

Esic medical college and hospital faridabad

jaseetha.sasidharan1@esic.nic.in9447812278

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026